Spectrum of movement disorders in neuroferritinopathy

Movement Disorders

Volumn 20, Issue 1, 2005, Pages 95-99

  Crompton, Douglas E ^a   Chinnery, Patrick F ^a,b,c   Bates, David ^d   Walls, Timothy J ^a   Jackson, Margaret J ^d   Curtis, Andrew J ^c   Burn, John ^c  

^a Regional Neurosciences Centre   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Chorea; Dystonia; Ferritin; Ferritin light chain; Movement disorder; Neuroferritinopathy

Indexed keywords

ALKALINE PHOSPHATASE; CREATINE KINASE; FERRITIN;

ADULT; AKINESIA; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHOREA; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; DYSARTHRIA; DYSTONIA; FERRITIN BLOOD LEVEL; GAIT DISORDER; HEAD TWITCH; HUMAN; MALE; MOTOR DYSFUNCTION; MUSCLE STIFFNESS; NEUROFERRITINOPATHY; NEUROLOGIC EXAMINATION; PHENOTYPE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TENDON REFLEX; VIDEORECORDING;

FERRITINS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MUTATION; NEOSTRIATUM; VIDEOTAPE RECORDING;

EID: 14044262975     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20284     Document Type: Article

References (11)

1. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001;28:350-354.
2. Chinnery PF, Curtis AR, Fey C, et al. Neuroferritinopathy in a French family with late onset dominant dystonia. J Med Genet 2003;40:e69.
3. Wills AJ, Sawle GV, Guilbert PR, Curtis AR. Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry 2002;73:91-92.
4. Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000;54:1746-1752.
5. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000;342:1560-1567.
6. Tassin J, Durr A, Bonnet AM, et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain 2000;123(Pt 6):1112-1121.
7. Vance JM, Pericak-Vance MA, Bowman MH, et al. Chorea-acanthocytosis: a report of three new families and implications for genetic counselling. Am J Med Genet 1987;28:403-410.
8. Muller U, Lee LV, Viterbo G, et al. The phenotype of X-linked torsion dystonia (XLTD). Am J Hum Genet 1990;47:A69.
9. Gasser T, Bressman S, Durr A, Higgins J, Klockgether T, Myers RH. State of the art review: molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosis. Mov Disord 2003;18:3-18.
10. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33-40.
11. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-349.